Gruttadauria Salvatore, di Francesco Fabrizio, Vizzini Giovanni-Battista, Luca Angelo, Spada Marco, Cintorino Davide, Li Petri Sergio, Pietrosi Giada, Pagano Duilio, Gridelli Bruno
Department of Surgery, University of Pittsburgh, Coordinator Abdominal Adult Transplant. ISMETT Mediterranean Institute for Transplant and Advanced Specialized Therapies, University of Pittsburgh Medical Center in Italy, 90127 Palermo, Italy.
World J Gastroenterol. 2009 Sep 28;15(36):4556-60. doi: 10.3748/wjg.15.4556.
To describe a condition that we define as early graft dysfunction (EGD) which can be identified preoperatively.
Small-for-size graft dysfunction following living-related liver transplantation (LRLT) is characterized by EGD when the graft-to-recipient body weight ratio (GRBWR) is below 0.8%. However, patients transplanted with GRBWR above 0.8% can develop dysfunction of the graft. In 73 recipients of LRLT (GRBWR > 0.8%), we identified 10 patients who developed EGD. The main measures of outcomes analyzed were overall mortality, number of re-transplants and length of stay in days (LOS). Furthermore we analyzed other clinical pre-transplant variables, intra-operative parameters and post transplant data.
A trend in favor of the non-EGD group (3-mo actuarial survival 98% vs 88%, P = 0.09; 3-mo graft mortality 4.7% vs 20%, P = 0.07) was observed as well as shorter LOS (13 d vs 41.5 d; P = 0.001) and smaller requirement of peri-operative Units of Plasma (4 vs 14; P = 0.036). Univariate analysis of pre-transplant variables identified platelet count, serum bilirubin, INR and Meld-Na score as predictors of EGD. In the multivariate analysis transplant Meld-Na score (P = 0.025, OR: 1.175) and pre-transplant platelet count (P = 0.043, OR: 0.956) were independently associated with EGD.
EGD can be identified preoperatively and is associated with increased morbidity after LRLT. A prompt recognition of EGD can trigger a timely treatment.
描述一种我们定义为早期移植物功能障碍(EGD)的情况,这种情况可在术前识别。
活体肝移植(LRLT)后小体积移植物功能障碍的特征是当移植物与受体体重比(GRBWR)低于0.8%时出现EGD。然而,接受GRBWR高于0.8%移植的患者也可能发生移植物功能障碍。在73例LRLT受者(GRBWR>0.8%)中,我们确定了10例发生EGD的患者。分析的主要结局指标为总死亡率、再次移植次数和住院天数(LOS)。此外,我们还分析了其他术前临床变量、术中参数和术后数据。
观察到非EGD组有优势趋势(3个月精算生存率98%对88%,P = 0.09;3个月移植物死亡率4.7%对20%,P = 0.07),以及住院时间更短(13天对41.5天;P = 0.001)和围手术期血浆单位需求量更小(4对14;P = 0.036)。术前变量的单因素分析确定血小板计数、血清胆红素、国际标准化比值(INR)和终末期肝病模型钠评分(Meld-Na评分)为EGD的预测指标。多因素分析中,移植时的Meld-Na评分(P = 0.025,比值比:1.175)和术前血小板计数(P = 0.043,比值比:0.956)与EGD独立相关。
EGD可在术前识别,且与LRLT后发病率增加相关。及时识别EGD可促使及时治疗。